title: Hyperdiploidy associated with a high BCR-ABL transcript level may identify patients at risk of progression in chronic myeloid leukemia.
authors: Department of Clinical and Molecular Bio-Medicine, Section of Hematology, Oncology and General Pathology, Catania, Italy. fsematol@tiscali.it
authors: Fabio
authors: F
authors: Stagno
authors: Paolo
authors: P
authors: Vigneri
authors: Maria Letizia
authors: ML
authors: Consoli
authors: Alessandra
authors: A
authors: Cupri
authors: Stefania
authors: S
authors: Stella
authors: Loredana
authors: L
authors: Tambè
authors: Michele
authors: M
authors: Massimino
authors: Livia
authors: L
authors: Manzella
authors: Francesco
authors: F
authors: Di Raimondo
mesh_terms: D000368:Aged; D004171:Diploidy; D016044:Fusion Proteins, bcr-abl / Q000096:biosynthesis*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism* / Q000473:pathology; D008297:Male; D012333:RNA, Messenger / Q000096:biosynthesis*; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D012307:Risk Factors
chemical_list: D012333:RNA, Messenger; D012334:RNA, Neoplasm; D016044:Fusion Proteins, bcr-abl